ReviewDrug design, development and therapy2021

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data.

Maddalena Napolitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.